Global Anticoagulants Market Status and Outlook 2018-2025

July 2018 | 178 pages | ID: G876900F0C6EN
99Strategy

Abstracts

Report Snapshot

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1: Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2: Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3: Product Segment Overview and Market Status
Part 4: Application / End-User Segment Overview and Market Status
Part 5: Region Segment Overview and Market Status
Part 6: Product & Application Segment Production & Demand by Region
Part 7: Market Forecast by Product, Application & Region
Part 8: Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9: Market Competition and Environment for New Entrants
Part 10: Conclusion

Market Segment as follows:

Key Companies

• Bayer
• Sanofi
• Boehringer Ingelheim
• Johnson & Johnson
• Genentech (Roche)
• AstraZeneca
• Bristol-Myers Squibb
• Aspen
• Lilly
• Otsuka
• Pfizer
• Daiichi Sankyo
• The Medicines Company

Market by Type

• Platelet aggregation inhibitors (PAI)
• Low-molecular-weight Heparin (LMWH)
• Direct thrombin inhibitor (DTI)
• Direct factor Xa inhibitors (DFXa)
• Vitamin K antagonists (VKA)
• Others

Market by Application

• VTE
• ACS/MI
• AF
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Anticoagulants Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Platelet aggregation inhibitors (PAI)
  3.1.2 Low-molecular-weight Heparin (LMWH)
  3.1.3 Direct thrombin inhibitor (DTI)
  3.1.4 Direct factor Xa inhibitors (DFXa)
  3.1.5 Vitamin K antagonists (VKA)
  3.1.6 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 VTE
  4.1.2 ACS/MI
  4.1.3 AF
  4.1.4 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Platelet aggregation inhibitors (PAI) Production by Region
    6.1.1.2 Low-molecular-weight Heparin (LMWH) Production by Region
    6.1.1.3 Direct thrombin inhibitor (DTI) Production by Region
    6.1.1.4 Direct factor Xa inhibitors (DFXa) Production by Region
    6.1.1.5 Vitamin K antagonists (VKA) Production by Region
    6.1.1.6 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 VTE Production by Region
    6.1.2.2 ACS/MI Production by Region
    6.1.2.3 AF Production by Region
    6.1.2.4 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Platelet aggregation inhibitors (PAI) Demand by Region
    6.2.1.2 Low-molecular-weight Heparin (LMWH) Demand by Region
    6.2.1.3 Direct thrombin inhibitor (DTI) Demand by Region
    6.2.1.4 Direct factor Xa inhibitors (DFXa) Demand by Region
    6.2.1.5 Vitamin K antagonists (VKA) Demand by Region
    6.2.1.6 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 VTE Demand by Region
    6.2.2.2 ACS/MI Demand by Region
    6.2.2.3 AF Demand by Region
    6.2.2.4 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Bayer
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Sanofi
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Boehringer Ingelheim
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Johnson & Johnson
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Genentech (Roche)
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 AstraZeneca
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Bristol-Myers Squibb
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Aspen
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Lilly
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Otsuka
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Pfizer
8.12 Daiichi Sankyo
8.13 The Medicines Company

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Anticoagulants Industry Dynamics & Regulations List
Table Global Anticoagulants Sales Revenue, Cost and Margin, 2015-2018E
Table Global Anticoagulants Market Status by Type 2015-2018E, in USD Million
Table Global Anticoagulants Market Status by Application 2015-2018E, in USD Million
Table Global Anticoagulants Market Status by Application 2015-2018E, in Volume
Table Global Anticoagulants Market by Region 2015-2018E, in USD Million
Table Global Anticoagulants Market Share by Region in 2018, in USD Million
Table Global Anticoagulants Market by Region 2015-2018E, in Volume
Table Global Anticoagulants Market Share by Region in 2018, in Volume
Table Platelet aggregation inhibitors (PAI) Production Value by Region 2015-2018E, in USD Million
Table Platelet aggregation inhibitors (PAI) Production Volume by Region 2015-2018E, in Volume
Table Low-molecular-weight Heparin (LMWH) Production Value by Region 2015-2018E, in USD Million
Table Low-molecular-weight Heparin (LMWH) Production Volume by Region 2015-2018E, in Volume
Table Direct thrombin inhibitor (DTI) Production Value by Region 2015-2018E, in USD Million
Table Direct thrombin inhibitor (DTI) Production Volume by Region 2015-2018E, in Volume
Table Direct factor Xa inhibitors (DFXa) Production Value by Region 2015-2018E, in USD Million
Table Direct factor Xa inhibitors (DFXa) Production Volume by Region 2015-2018E, in Volume
Table Vitamin K antagonists (VKA) Production Value by Region 2015-2018E, in USD Million
Table Vitamin K antagonists (VKA) Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table VTE Production Value by Region 2015-2018E, in USD Million
Table VTE Production Volume by Region 2015-2018E, in Volume
Table ACS/MI Production Value by Region 2015-2018E, in USD Million
Table ACS/MI Production Volume by Region 2015-2018E, in Volume
Table AF Production Value by Region 2015-2018E, in USD Million
Table AF Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Platelet aggregation inhibitors (PAI) Market Size by Region 2015-2018E, in USD Million
Table Platelet aggregation inhibitors (PAI) Market Size by Region 2015-2018E, in Volume
Table Low-molecular-weight Heparin (LMWH) Market Size by Region 2015-2018E, in USD Million
Table Low-molecular-weight Heparin (LMWH) Market Size by Region 2015-2018E, in Volume
Table Direct thrombin inhibitor (DTI) Market Size by Region 2015-2018E, in USD Million
Table Direct thrombin inhibitor (DTI) Market Size by Region 2015-2018E, in Volume
Table Direct factor Xa inhibitors (DFXa) Market Size by Region 2015-2018E, in USD Million
Table Direct factor Xa inhibitors (DFXa) Market Size by Region 2015-2018E, in Volume
Table Vitamin K antagonists (VKA) Market Size by Region 2015-2018E, in USD Million
Table Vitamin K antagonists (VKA) Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table VTE Market Size by Region 2015-2018E, in USD Million
Table VTE Market Size by Region 2015-2018E, in Volume
Table ACS/MI Market Size by Region 2015-2018E, in USD Million
Table ACS/MI Market Size by Region 2015-2018E, in Volume
Table AF Market Size by Region 2015-2018E, in USD Million
Table AF Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalAnticoagulants Forecast by Type 2019F-2025F, in USD Million
Table Anticoagulants Forecast by Type 2019F-2025F, in Volume
Table Anticoagulants Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Anticoagulants Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Anticoagulants Market Forecast by Region 2019F-2025F, in USD Million
Table Anticoagulants Market Forecast by Region 2019F-2025F, in Volume
Table Bayer Information
Table Anticoagulants Sales, Cost, Margin of Bayer
Table Sanofi Information
Table Anticoagulants Sales, Cost, Margin of Sanofi
Table Boehringer Ingelheim Information
Table Anticoagulants Sales, Cost, Margin of Boehringer Ingelheim
Table Johnson & Johnson Information
Table Anticoagulants Sales, Cost, Margin of Johnson & Johnson
Table Genentech (Roche) Information
Table Anticoagulants Sales, Cost, Margin of Genentech (Roche)
Table AstraZeneca Information
Table Anticoagulants Sales, Cost, Margin of AstraZeneca
Table Bristol-Myers Squibb Information
Table Anticoagulants Sales, Cost, Margin of Bristol-Myers Squibb
Table Aspen Information
Table Anticoagulants Sales, Cost, Margin of Aspen
Table Lilly Information
Table Anticoagulants Sales, Cost, Margin of Lilly
Table Otsuka Information
Table Anticoagulants Sales, Cost, Margin of Otsuka
Table Pfizer Information
Table Anticoagulants Sales, Cost, Margin of Pfizer
Table Daiichi Sankyo Information
Table Anticoagulants Sales, Cost, Margin of Daiichi Sankyo
Table The Medicines Company Information
Table Anticoagulants Sales, Cost, Margin of The Medicines Company
Table Global Anticoagulants Sales Revenue by Company 2015-2017, in USD Million
Table Global Anticoagulants Sales Volume by Company 2015-2017, in Volume
Table Global Anticoagulants Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Anticoagulants Picture
Figure Anticoagulants Industry Chain Diagram
Figure Global Anticoagulants Sales Revenue 2015-2018E, in USD Million
Figure Global Anticoagulants Sales Volume 2015-2018E, in Volume
Figure Global Anticoagulants Market Status by Type 2015-2018E, in Volume
Figure North America Anticoagulants Market Size and Growth 2015-2018E, in USD Million
Figure North America Anticoagulants Market Size and Growth 2015-2018E, in Volume
Figure Europe Anticoagulants Market Size and Growth 2015-2018E, in USD Million
Figure Europe Anticoagulants Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Anticoagulants Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Anticoagulants Market Size and Growth 2015-2018E, in Volume
Figure South America Anticoagulants Market Size and Growth 2015-2018E, in USD Million
Figure South America Anticoagulants Market Size and Growth 2015-2018E, in Volume
Figure Middle East Anticoagulants Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Anticoagulants Market Size and Growth 2015-2018E, in Volume
Figure Africa Anticoagulants Market Size and Growth 2015-2018E, in USD Million
Figure Africa Anticoagulants Market Size and Growth 2015-2018E, in Volume
Figure Global Anticoagulants Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Anticoagulants Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Anticoagulants Sales Price Forecast 2019F-2025F
Figure Global Anticoagulants Gross Margin Forecast 2019F-2025F
Figure Global Anticoagulants Sales Revenue by Company in 2018, in USD Million
Figure Global Anticoagulants Price by Company in 2018
Figure Global Anticoagulants Gross Margin by Company in 2018